AdvisorShares Pure US Cannabis ETF (MSOS) is a publicly traded the market company. As of May 21, 2026, MSOS trades at $4.51 with a market cap of $0 and a P/E ratio of 0.00. MSOS moved +2.96% today. Year to date, MSOS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces MSOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Medical Cannabis Rescheduling to Unlock Millions in Tax Deductions: The Administration moved medical cannabis from Schedule I to Schedule III, removing IRS code 280E restrictions and potentially unlocking millions in tax deductions for MSOS ETF holdings. Only medical cannabis qualifies for these deductions before a June DEA hearing on recreational classification, forcing firms to consider strategic shifts in operations.
| Metric | Value |
|---|---|
| Price | $4.51 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 4.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
MSOS analyst coverage data. Average price target: $0.00.